Insurance, race, and socioeconomic disparities in systemic therapy receipt for melanoma in the United States: a systematic review

Europe PMC Europe PMC 1 Sign in | Create an account https://orcid.org https://plus.europepmc.org Europe PMC Menu About About Europe PMC Preprints in Europe PMC Governance & funding Mission & roadmap Outreach Tools Tools overview Article status monitor ORCID article claiming Grant finder External links service RSS feeds About SciLite annotations Annotations submission service Developers Developer resources Articles RESTful API Grants RESTful API API case studies SOAP web service Annotations API OAI service Bulk downloads Developers Forum Support User guide Search syntax guide Contact us Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus

Related documents

• Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors#868233
• Improving Rates of Colorectal Cancer Screening Among Never Screened Patients#829992
• A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma#121346
• Investigating Participation Patterns Among Stage IV Melanoma Patients#868562
• Needs, distress, state-of-health and quality-of-life in survivors of stage III melanoma: Results from the cross-sectional MESSAGE study / E.-M. Skoda, C. Jansen, L. Peltz, A. Schweda, M. Teufel, E. Livingstone, L. Zimmer, A. Forschner, M. Reitmajer, M. Erdmann, L. Susok, R. Rompel, D. Debus, W.K. Peitsch, X. Garza Vazquez, J. Raguz, W. Harth, S. Grabbe, F. Meier, K. Kaminski, E. Tagari, K. Schober, D. Schadendorf#1078571